• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Argenx - Articles and news items

ARGX-113

Argenx announces initial ARGX-113 Phase 1 study results

Industry news / 6 January 2016 / Victoria White

The objective of the Phase 1 study is to evaluate the safety and tolerability of ARGX-113 and to identify a potential dose for future Phase 2 studies…

 

Win an Amazon Gift Card worth up to €100!TAKE OUR SURVEY
+ +